国内中药药物经济学评价的系统评价及质量评估

Systematic economic assessment and quality evaluation for traditional Chinese medicines

为了解国内文献关于中药药物经济学研究情况,以分析国内中药药物经济学评价研究现状,探求其所存在的问题。运用计算机检索中文期刊全文数据库(CNKI)、中文科技期刊全文数据库(VIP)、万方数据库、中国生物医学文摘数据库(CBM),纳入截止2014年为止所有国内专业期刊上发表的中药药物经济学评价文献进行系统评估和质量评价。研究最终纳入文献50篇,从文题、年份、作者身份、经费来源、研究疾病种类、研究角度、研究设计类型、研究目标人群情况、研究目标人群来源、研究时限、成本计算、效果指标、分析技术和敏感度分析等多方面对纳入中药药物经济学文献进行系统评价及质量评估,最终质量水平得分0.74,文献质量偏低。研究结果发现目前存在中药药物经济学研究探索相对较少、研究时限不足够长、评价方法过于单一等问题,这也将是今后不懈努力的方向。

To learn about the economic studies on traditional Chinese medicines in domestic literatures, in order to analyze the cur- rent economic assessment of traditional Chinese medicines and explore the existing problems. Efforts were made to search CNKI, VIP, Wanfang database and CBM by computer and include all literatures about economic assessment of traditional Chinese medicines pub- lished on professional domestic journals in the systematic assessment and quality evaluation. Finally, 50 articles were included in the study, and the systematic assessment and quality evaluation were made for them in terms of titles, year, authors＇ identity, expense source, disease type, study perspective, study design type, study target, study target source, time limit, cost calculation, effect indicator, analytical technique and sensitivity analysis. The finally quality score was 0.74, which is very low. The results of the study showed insufficient studies on economics of traditional Chinese medicines, short study duration and simple evaluation methods, which will be solved through unremitting efforts in the future.